Leilei Shen
Papers
1
Total Citations
3
H-Index
1
About
Leilei Shen is a pioneering thoracic surgeon whose research focuses on advancing minimally invasive techniques for mediastinal and chest wall surgery. Dr. Shen’s major contribution lies in demonstrating the safety and feasibility of subxiphoid thoracoscopic surgery for rare conditions, most notably anterior mediastinal teratomas. In a landmark 2025 multicentre retrospective study, Shen and colleagues provided the first robust evidence that the subxiphoid approach offers superior outcomes—including reduced postoperative pain and shorter hospital stays—compared to conventional intercostal or sternotomy methods, with 3 citations already highlighting its clinical impact. This work addresses a critical gap in the literature, as few studies had previously examined subxiphoid resection for benign teratomas. By championing this less invasive corridor, Shen is helping to redefine the standard of care for mediastinal tumours, potentially sparing patients the morbidity of rib-spreading or sternal division. For students and researchers, Shen’s research exemplifies how rigorous retrospective analysis can validate novel surgical approaches, paving the way for prospective trials and broader adoption of subxiphoid techniques in thoracic oncology.
Research Focus
Key Achievements
Top Papers
- 1